Cytek Biosciences, Inc.

NASDAQ:CTKB

4.2 (USD) • At close March 14, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019
Revenue 200.453193.015164.036127.9592.83957.883
Cost of Revenue 89.34783.58963.06248.80641.12929.209
Gross Profit 111.106109.426100.97479.14451.7128.674
Gross Profit Ratio 0.5540.5670.6160.6190.5570.495
Reseach & Development Expenses 39.40244.15134.85824.44213.6938.931
General & Administrative Expenses 43.11342.47234.6920.8259.376.739
Selling & Marketing Expenses 49.11449.14833.2324.7114.98810.241
SG&A 92.22791.6267.9245.53524.35816.98
Other Expenses 001.018-1.5270.9940.252
Operating Expenses 131.629137.271102.77869.97738.05125.911
Operating Income -20.523-27.845-1.8266.44713.6593.726
Operating Income Ratio -0.102-0.144-0.0110.050.1470.064
Total Other Income Expenses Net 14.82312.1363.064-3.2190.7710.962
Income Before Tax -5.7-15.7091.265.94814.43-16.294
Income Before Tax Ratio -0.028-0.0810.0080.0460.155-0.281
Income Tax Expense 0.32-3.561-1.2241.505-4.9810.533
Net Income -6.02-12.1482.5764.41719.411-16.827
Net Income Ratio -0.03-0.0630.0160.0350.209-0.291
EPS 0-0.090.0190.0330.024-0.13
EPS Diluted 0-0.090.0190.0330.024-0.13
EBITDA -20.523-4.4089.53510.39915.366-15.984
EBITDA Ratio -0.102-0.0230.0230.060.1660.07